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ta.2012.1Abstract Introduction: Papillary carcinoma is the commonest subtype of thyroid cancer. Patients
are treated with radioactive iodine (RAI), and monitored with RAI scans, serum thyroglobulin lev-
els, and cervical ultrasonography. Elevated serum thyroglobulin despite a negative RAI scan is
termed the TENIS syndrome (Truncated Expression of the NIS; NIS represents the sodium-iodide
symporter). Alternative imaging is then indicated.
Method/Result: A female Caucasian patient with papillary thyroid carcinoma had been followed
up at our Thyroid Cancer clinic. A diagnostic scan revealed residual thyroid tissue. RAI ablation of
the thyroid remnant was performed with 80 mCi of RAI. Two- and ﬁve-year follow-up scans were
clear. However, thyroglobulin levels remained high, thus a diagnosis of TENIS syndrome was
made.
An F-18 FDG PET/CT scan was performed which demonstrated inhomogeneous liver uptake
(SUV > 6). Abdominal CT conﬁrmed multiple liver lesions; ultrasound-guided FNA of these
revealed several groups of malignant cells.
Conclusion: Persistently elevated thyroglobulin levels in the presence of a negative whole-body
RAI scan are of great concern. In this patient with unusual liver metastases from papillary thyroid
cancer, and relatively low thyroglobulin levels despite signiﬁcant metastases, F-18 FDG PET/CT
has once more proved its efﬁcacy in the evaluation of patients with the TENIS syndrome.
ª 2012 Egyptian Society of Ear, Nose, Throat and Allied Sciences.
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1.0021. Introduction
Thyroid carcinoma, though a rare tumour in the setting of gen-
eral oncology, is the commonest endocrine tumour (90%), and
papillary carcinoma is its commonest subtype (70–80%) in io-
dine-replete populations.1,2 It is commoner in females (M:F ra-
tio of 3:1) and has a peak age incidence of 30–50 years.
Papillary thyroid carcinoma typically spreads to locoregional
lymph nodes and to the lungs.ces. Production and hosting by Elsevier B.V. All rights reserved.
Figure 1 Whole-body radioiodine-131 scan.
38 Y.A. Onimode et al.Following total thyroidectomy and radioactive iodine abla-
tion, patients are monitored with whole-body iodine scans and
serum thyroglobulin levels.3 In this setting, thyroglobulin is a
sensitive tumour marker, even more under so the stimulation
of thyroid stimulating hormone (TSH) (98% compared to
80% under TSH suppression).4,5 A varying proportion of pa-Table 1 Thyroglobulin, antithyroglobulin antibody and thyroid ho
Tg* (ng/ml) Anti-Tg Antibody (ng/m
On T4 suppression 0.5 <10.0
Oﬀ T4 suppression 10 10
* Tg: Thyroglobulin.
** TSH: thyroid stimulating hormone.
Figure 2 Hepatic metastases as seen ontients (up to 56%)6–9 may exhibit elevation of thyroglobulin in
the presence of a negative I-131 whole-body scan. This condi-
tion has been termed the TENIS syndrome (Truncated Expres-
sion of the NIS, NIS being an acronym for the sodium-iodide
symporter). The syndrome has been attributed to several pos-
sible aetiologies, such as small dose of radioiodine used for the
diagnostic scan, ‘‘stunning’’ of radioiodine (RAI) uptake by
functional thyroid tissue, dedifferentiation of the carcinoma,
loss of function mutation of the NIS, iodine ingestion/admin-
istration blocking RAI uptake, absence of immunoreactive
cytoplasmic thyroglobulin and thyroxine,10,11 or to tumour
size below gamma camera resolution.12 When compared to
other alternative imaging agents, F-18 FDG PET/CT imaging,
with a sensitivity of 85–94% and a speciﬁcity of 90–95%,13 has
been declared by a consensus as the most suitable modality for
detecting tumour spread and recurrence in such instances. This
claim is substantiated by other studies.14,15 It was also ob-
served that the sensitivity of FDG PET imaging increased in
patients with the TENIS syndrome.16,17
2. Method/case report
A 41 year old female patient known with papillary thyroid
carcinoma had been followed up at our thyroid cancer clinic.
Following completion thyroidectomy, she had a diagnostic
radioiodine scan, which revealed the presence of residual
thyroid tissue. RAI ablation of the thyroid remnant was per-
formed with 80 mCi I-131 in December 2000. The patient thenrmone assays at 5th year follow-up.
l) T4 (pmol/L) T3 (pmol//L) **TSH (mIU/L)
19.5 4.3 0.3
2.6 0.7 36.54
patient’s F-18 FDG PET/CT scan.
Figure 3 Inhomogeneous hepatic metastases as seen on transaxial slices of (A) F-18 FDG PET, (B) CT and (C) fused PET/CT scan.
An unusual presentation of the TENIS syndrome 39underwent follow-up scans at 6 months, 1 year, 2 years
and 5 years afterwards, which were all clear (see 5-year
scan, Fig. 1). However, a sudden increase in the thyroglobu-
lin (Tg) levels was noted at her ﬁve-year follow-up (Table 1);
the patient was thus diagnosed as having the TENIS
syndrome.
3. Result
PET/CT imaging (Figs. 2 and 3) demonstrated inhomogeneous
uptake in the liver, with focal increased activity in the right
lobe; in segments 4a, 5 and 8 (SUV 6.73). It also showed a
pedunculated inhomogeneous mass arising from segment 5
of the liver (SUV 5.09). Abdominal CT scan ﬁndings were
consistent with multiple liver lesions. Ultrasound-guided
FNA biopsy of the liver metastases revealed several groups
of malignant cells compatible with metastatic papillary thyroid
carcinoma. The patient was counselled regarding her prognosis
and maintained on L-thyroxine 150 lg daily.
4. Conclusion
Serum thyroglobulin is an established tumour marker for mon-
itoring papillary thyroid carcinoma, after total thyroidectomy
and lymph node clearance. Persistently elevated thyroglobulin
levels in the presence of a negative whole-body RAI scan are of
great concern. In this patient with unusual liver metastases
from papillary thyroid cancer, and relatively low thyroglobulin
levels despite signiﬁcant metastases, F-18 FDG PET/CT hasonce more proved its efﬁcacy for further evaluation of patients
with the TENIS syndrome.
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